Another possible vaccine from French company is delayed

Sanofi is betting on two horses in the vaccine race, but the original schedule for both projects has now been postponed.

A vaccine candidate against covid-19 developed by the French Sanofi and the American Translate Bio will not be ready for use this year.

This is what the top manager of the French pharmaceutical company informs the newspaper Le Journal du Dimanche, according to the news agency Reuters.

In December, Sanofi stated that it was aiming to get the product approved in the second half of 2021. But that is not how it will go.

– The vaccine will not be ready this year, but it may come into use at a later date. Especially if the fight against variants (of the virus, ed.) Should continue, says top manager Paul Hudson to the newspaper without providing further information.

Clinical trials with the agent, based on the same mRNA technology as the approved vaccines from Moderna and Pfizer / BioNTech, are expected to begin this quarter.

This is the second time that Sanofi has been too optimistic about when a vaccine might be approved for marketing.

The company is developing two vaccines against covid-19, but the second project in collaboration with the British GlaxoSmithKline is also not following the original schedule.

The vaccine should have been on the market in June 2021, but the parties announced in December that it was not expected to obtain approval until the end of the year.

The drug is among six possible corona vaccines that Denmark has the option to buy.

In January, Sanofi announced that it had entered into an agreement to fill, package and distribute millions of doses of Pfizer and BioNTech’s vaccine from July.

The unusual collaboration with rival Pfizer should help increase the pace of vaccination efforts, wrote financial media Bloomberg.

The agreement will secure an additional 125 million doses to the EU.

“We had a minor delay for one of our vaccine candidates and decided to use the time to mobilize our production capacity to help it from Pfizer,” said Olivier Bogillot, Sanofi’s country manager for France.

According to Bogillot, this is the first time a pharmaceutical company is helping to make a vaccine for a competitor.

Countries around the world have since the beginning of the year launched mass vaccination campaigns in the hope of curbing the spread of infection.

/ ritzau /

Source: – Nyheder – Alle artikler by

*The article has been translated based on the content of – Nyheder – Alle artikler by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!